Execution on AI Deals, Margin Recovery Under Watch
Hexaware reports Q1 FY-2027 (Apr-Jun 2026) results on July 29. With flat constant-currency growth and EBIT margins under pressure in H1, the Street will focus on deal velocity, customer concentration, and management's confidence in the 13–14% margin guide.
Hexaware reports Q1 FY-2027 on July 29, after a softer prior quarter (Q1 CY26, ended Mar 2026) that saw constant-currency revenue growth slow to 3.2% YoY and EBIT margins compress 133 bps to 13.0%. The Street expects a muted first half (management guided 13–14% full-year EBIT, with recovery back-weighted to H2), but will scrutinize two things: (1) whether the company is converting recent AI deal wins into meaningful revenue, and (2) whether Q1 margins point to a trajectory back to historical 14%+ levels by year-end.
What to Expect
~₹3,600–3,650 Cr
Implies ~6–8% YoY growth in constant currency; INR terms flattered by rupee weakness vs prior-year base
~12.5–13.0%
H1 expected to be trough; management target is 13–14% for the full year with ramp in H2
Watch the trends
Prior quarter saw modest onshore hiring for AI/transformation roles; look for signs of investment completion or new ramp
34 customers >$10M
Up from 32 in Q4 CY25; incremental wins in AI transformation a key signal for H2 growth acceleration
A strong Q1 print would show revenue hitting the top of guidance (7.6%+ YoY, INR terms), EBIT margin stabilizing near 13% (not re-compressing), and commentary affirming that AI deal wins are ramping into production and the margin glide path is intact. A weak print would be low single-digit constant-currency growth, EBIT margin below 12.5% with no credible commentary on H2 recovery, or a cut to full-year guidance. Guidance holds are not priced in; the market expects confidence reaffirmed.
On Track?
Hexaware has guided 7.6% revenue growth for CY26 and EBIT margins of 13–14%, expecting the second half to be higher-margin than H1. Q1 CY26 (ended Mar 26) delivered 3.2% constant-currency growth and 13.0% EBIT—not a miss, but a signal that the top line faces headwinds (client modernization cycles still soft; deal velocity lumpier than prior cycles). Management attributed the margin pressure to onshore wage inflation and project-mix effects, implying H2 will be better as large deals ramp. The Street is tracking whether this plays out or whether the full-year guide needs downside revision.
What the Street Says
Since Last Quarter
1 · Strategic AI/hyperscaler leadership
Jul 18: Eravi Gopan elevated to lead all hyperscaler and strategic tech partnerships; Jul 9: Srinivasan Panchapakesan appointed Chief Platform Officer (newly created role). Both moves signal an organizational shift toward platform-led, AI-native go-to-market. Operationally bullish, but execution risk.
2 · Anthropic authorized reseller (Jun 25)
Hexaware appointed as Anthropic Authorized Reseller for Amazon Bedrock, enabling Claude model sales to enterprise clients. Signals early-mover positioning in GenAI adoption as-a-service for large accounts. Margin model TBD.
3 · Strategic partnerships + new product launches
Jun 30: Launched Tensai® for Reasoning Ops (agentic ITOps); Jun 3 & Jul 6: partnerships with HBSUK and SmartRent for AI-native operations. These are investments in recurring-revenue/SaaS positioning (higher-margin over time).
4 · Shareholder base shift
FII ownership fell 390 bps to 4.2% (from 8.15% last quarter). DII rose 373 bps to 15.04%. The selloff by foreign investors post-valuation reset (ATH ₹807) has been offset by domestic appetite. Suggests domestic confidence in execution outpacing global macro skepticism.
5 · M&A + capex: CPS acquisition + UK expansion
May 20: Acquired Consulting Professionals Services (UK/UAE, £11M) for consulting footprint; Jun 17: Announced £25M investment in UK to create 1,200 jobs over 3–5 years. Signals confidence in client demand and willingness to front-load cost to capture share.
6 · Favorable patent ruling
Jun 12: US District Court dismissed all claims in patent litigation filed by Natsoft/Updraft. Removes a regulatory/litigation overhang; routine legal win, not material to results.
7 · Trading window closed (Jun 29)
Closure effective Jul 1–48 hours after results announcement (standard pre-earnings blackout). No insider trading signals expected.
The Setup
Hexaware enters Q1 FY-2027 at a valuation inflection: the stock has halved from ATH (₹807 → ₹552), and the consensus expects margin recovery and AI-led deal acceleration to re-rate it higher. The company has three macro tailwinds (AI transformation spending, hyperscaler growth, platform expansion) and one headwind (cautious client spending in first half = lower deal momentum). Management's commentary on H2 margin recovery and AI deal velocity will be parsed line-by-line; any hint of conservatism or guide cut could trigger a retest of recent lows. Conversely, a reaffirmation of 13–14% EBIT + evidence of AI deal wins ramping into production would support the analyst bull case and the 57% upside to consensus target.
Three Things to Watch on Result Day
1. Margin trajectory & commentary: Is EBIT margin ≥ 12.8%? Is management confident in the H2 recovery narrative, or are there signs of delays? Any guidance revision (up or down)? 2. Large-deal traction: Customer count >$10M (expect 35–36 vs. 34 prior)? Deal pipeline and win rates in AI/transformation—is the recent leadership churn translating to pipeline momentum? 3. Capital allocation + capex intensity: How much cash is the UK investment consuming? Is organic free cash flow (the company's historic strength, 125%+ LTM OCF-to-PAT) holding up amid M&A and expansion spend?
Hexaware reports on July 29 into a backdrop of reset valuation, bullish analyst consensus, and a company in transition—investing heavily in AI/platform/UK expansion while guiding for margin recovery in H2. The quarter will be read for two things: (1) whether Q1 EBIT margin signals H2 recovery is on track (management credibility rides on this), and (2) whether the flurry of AI partnerships and leadership appointments have begun to convert into revenue growth >6% in constant currency. A result that reaffirms both would support the 57% consensus upside to ₹870+; a miss on either would reset the narrative.
Hexaware Q1 FY27: consolidated PAT falls 13% YoY (~17% adjusted) as margins compress
PAT -13.04% YoY · revenue +17.93% · margins compressing
₹3,845.2 Cr
+17.93% YoY
₹330.2 Cr
-13.04% YoY
8.7%
-2.4pp YoY
₹5.41
Hexaware's consolidated (primary basis) Q1 FY-2027 (Apr-Jun 2026) print shows revenue of ₹3,845.2 Cr, up 17.9% YoY and 6.4% QoQ, but PAT of ₹330.2 Cr down 13.0% YoY and 6.1% QoQ, with net margin compressing to 8.6% from 11.1% a year ago and 9.7% last quarter. Adjusting for one-offs on both sides — this quarter's ₹4.7 Cr CPS acquisition transaction cost versus a net ~₹27.2 Cr one-off gain embedded in the year-ago consolidated base (a ₹158.7 Cr contingent-consideration gain on an earlier acquisition, partly offset by a ₹78.2 Cr customer-dispute charge, ₹43.5 Cr severance costs, ₹22.7 Cr ERP-transformation costs and ₹39.4 Cr customer-relationship impairment) — underlying consolidated PAT growth is closer to -17%, worse than the reported -13%, because last year's base was itself inflated by a one-off gain that has now rolled off.
Q1 FY-2027 vs prior quarters
The margin drag sits mainly on the employee-cost and other-income lines: employee benefits expense rose to ₹2,266.4 Cr (58.9% of income) from ₹1,907.8 Cr a year ago, while other income swung to a net loss of ₹50.1 Cr, driven by a ₹78.3 Cr forex loss this quarter versus a ₹13.7 Cr loss a year ago. This is broadly consistent with management's own prior guidance of a weak H1 on deal-ramp and rebadging costs ahead of an H2 margin recovery toward the guided 13-14% full-year EBIT band — this quarter's consolidated EBIT-equivalent margin (profit before exceptional items and tax over total income) works out to about 11.6%, below that full-year range but in line with the flagged weak-H1 framing.
The stock went into the print at ₹618.3, up 20.1% over the past month of trading.
For context: revenue is at a 6-quarter high.
What the summary numbers don't show
Basic EPS ₹5.41 (consolidated) vs ₹6.25 YoY and ₹5.77 QoQ.
Management guides for full-year CY26 revenue growth to be better than CY25's 7.6%, with a weak Q1 followed by sequential quarterly acceleration driven by strong deal wins and a record $4B+ pipeline. Full-year EBIT margin is projected at 13-14%, impacted by significant H1 deal ramp-up and rebadging costs but expected to
— This quarter: met
A striking divergence: standalone (parent-only) PAT actually grew 18.1% YoY to ₹200.0 Cr on revenue growth of 15.0%, the opposite direction of the consolidated decline — the gap traces to the one-off contingent-consideration gain and associated impairment/charges that were booked at the Group (subsidiary) level last year, not at the standalone entity, so the consolidated YoY comparison carries a much harder prior-year base than the standalone one. Reported revenue growth (+17.9% YoY consolidated) also runs well ahead of the pre-result read of "flat constant-currency growth," implying the headline is significantly boosted by recent inorganic additions (CPS, Mobiquity, SMC Squared and other subsidiaries) rather than organic expansion — a distinction the street will likely probe. No consensus PAT/revenue estimate for this specific quarter could be confirmed via web search, so vsStreet is marked unknown; the only available read is the bullish pre-result analyst consensus (Buy, 15 analysts, 12-month target ₹870-888) built on the AI-deal-acceleration and margin-recovery thesis. Corporate developments this quarter — the May 28, 2026 acquisition of UK-based Consulting Professionals Services (CPS) for GBP 6 million upfront plus up to GBP 5 million contingent consideration, the dismissal of Natsoft/Updraft's USD 500 million patent-infringement suit by a US federal court, and new hyperscaler-partnership and Chief Platform Officer leadership appointments — support the AI/hyperscaler and large-deal narrative but did not materially move this quarter's P&L beyond the ₹4.7 Cr CPS transaction cost.
W1
H2 EBIT margin recovery toward management's guided 13-14% full-year range (this quarter's consolidated EBIT-equivalent margin ~11.6%, standalone ~13.0%).
W2
Integration and further cost impact of the CPS acquisition (GBP 6 mn upfront + up to GBP 5 mn earnout, closed May 28, 2026).
W3
Whether reported revenue growth (+17.9% YoY) converges toward the flagged flat constant-currency organic growth trend as acquisition-led boost normalises.